Predicting survival of de novo metastatic breast cancer in Asian women: Systematic review and validation study

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Miao, Hui ^a   Hartman, Mikael ^a,b,c   Bhoo Pathy, Nirmala ^d,e   Lee, Soo Chin ^a   Taib, Nur Aishah ^f   Tan, Ern Yu ^g   Chan, Patrick ^g   Moons, Karel G M ^e   Wong, Hoong Seam ^d   Goh, Jeremy ^b   Rahim, Siti Mastura ^h   Yip, Cheng Har ^f   Verkooijen, Helena M ^a,e  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c KAROLINSKA INSTITUTE   (Sweden)

^d HOSPITAL KUALA LUMPUR   (Malaysia)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f UNIVERSITY OF MALAYA   (Malaysia)

^g TAN TOCK SENG HOSPITAL   (Singapore)

^h MINISTRY OF HEALTH   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASIAN; BRAIN METASTASIS; BREAST METASTASIS; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SURVIVAL; DECISION MAKING; DISEASE FREE INTERVAL; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALAYSIA; PREDICTION; SCORING SYSTEM; SINGAPORE; SYSTEMATIC REVIEW; VALIDATION STUDY; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST TUMOR; METASTASIS; MORTALITY; PATHOLOGY; PROGNOSIS;

OLIGONUCLEOTIDE; SURKEX;

ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; FEMALE; HUMANS; MALAYSIA; NEOPLASM METASTASIS; OLIGONUCLEOTIDES; PROGNOSIS; SINGAPORE;

EID: 84898832005     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093755     Document Type: Article

References (61)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
2. Yip CH, Taib NA, Mohamed I (2006) Epidemiology of breast cancer in Malaysia. Asian Pac J Cancer Prev 7: 369-374.
3. Tan EY, Wong HB, Ang BK, Chan MY (2005) Locally advanced and metastatic breast cancer in a tertiary hospital. Ann Acad Med Singapore 34: 595-601.
4. Lim SE, Back M, Quek E, Iau P, Putti T, et al. (2007) Clinical observations from a breast cancer registry in Asian women. World J Surg 31: 1387-1392. (Pubitemid 46945376)
5. Chopra R (2001) The Indian scene. J Clin Oncol 19: 106S-111S.
6. Sant M, Allemani C, Berrino F, Coleman MP, Aareleid T, et al. (2004) Breast carcinoma survival in Europe and the United States. Cancer 100: 715-722. (Pubitemid 38176848)
7. Agarwal G, Pradeep PV, Aggarwal V, Yip CH, Cheung PS (2007) Spectrum of breast cancer in Asian women. World J Surg 31: 1031-1040. (Pubitemid 46716756)
8. Ly BH, Nguyen NP, Vinh-Hung V, Rapiti E, Vlastos G (2010) Loco-regional treatment in metastatic breast cancer patients: is there a survival benefit? Breast Cancer Res Treat 119: 537-545.
9. Chang J, Clark GM, Allred DC, Mohsin S, Chamness G, et al. (2003) Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor. Cancer 97: 545-553. (Pubitemid 36125831)
10. Khodari W, Sedrati A, Naisse I, Bosc R, Belkacemi Y (2013) Impact of locoregional treatment on metastatic breast cancer outcome: A review. Crit Rev Oncol Hematol 87(1):69-79.
11. Perez-Fidalgo JA, Pimentel P, Caballero A, Bermejo B, Barrera JA, et al. (2011) Removal of primary tumor improves survival in metastatic breast cancer. Does timing of surgery influence outcomes? Breast 20: 548-554.
12. Tai P, Yu E, Vinh-Hung V, Cserni G, Vlastos G (2004) Survival of patients with metastatic breast cancer: twenty-year data from two SEER registries. BMC Cancer 4: 60.
13. Todd M, Shoag M, Cadman E (1983) Survival of women with metastatic breast cancer at Yale from 1920 to 1980. J Clin Oncol 1: 406-408. (Pubitemid 14181202)
14. Largillier R, Ferrero JM, Doyen J, Barriere J, Namer M, et al. (2008) Prognostic factors in 1,038 women with metastatic breast cancer. Ann Oncol 19: 2012-2019.
15. Andre F, Slimane K, Bachelot T, Dunant A, Namer M, et al. (2004) Breast cancer with synchronous metastases: trends in survival during a 14-year period. J Clin Oncol 22: 3302-3308. (Pubitemid 41103686)
16. Rapiti E, Verkooijen HM, Vlastos G, Fioretta G, Neyroud-Caspar I, et al. (2006) Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. J Clin Oncol 24: 2743-2749. (Pubitemid 46630571)
17. Pathy NB, Verkooijen HM, Taib NA, Hartman M, Yip CH (2011) Impact of breast surgery on survival in women presenting with metastatic breast cancer. Br J Surg 98: 1566-1572.
18. Ruiterkamp J, Voogd AC, Bosscha K, Tjan-Heijnen VC, Ernst MF (2010) Impact of breast surgery on survival in patients with distant metastases at initial presentation: a systematic review of the literature. Breast Cancer Res Treat 120: 9-16.
19. Degner LF, Kristjanson LJ, Bowman D, Sloan JA, Carriere KC, et al. (1997) Information needs and decisional preferences in women with breast cancer. JAMA 277: 1485-1492. (Pubitemid 27208893)
20. Glare P, Virik K, Jones M, Hudson M, Eychmuller S, et al. (2003) A systematic review of physicians' survival predictions in terminally ill cancer patients. BMJ 327: 195-198. (Pubitemid 36920584)
21. Ravdin PM, Siminoff LA, Davis GJ, Mercer MB, Hewlett J, et al. (2001) Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol 19: 980-991. (Pubitemid 32176272)
22. Todd JH, Dowle C, Williams MR, Elston CW, Ellis IO, et al. (1987) Confirmation of a prognostic index in primary breast cancer. Br J Cancer 56: 489-492. (Pubitemid 17146357)
23. Michaelson JS, Chen LL, Bush D, Fong A, Smith B, et al. (2011) Improved web-based calculators for predicting breast carcinoma outcomes. Breast Cancer Res Treat 128: 827-835.
24. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P(2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097.
25. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, et al. (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370: 1453-1457.
26. Pathy NB, Yip CH, Taib NA, Hartman M, Saxena N, et al. (2011) Breast cancer in a multi-ethnic Asian setting: results from the Singapore-Malaysia hospital-based breast cancer registry. Breast 20 Suppl 2: S75-80.
27. Greene FL, American Joint Committee on Cancer., American Cancer Society. (2002) AJCC cancer staging manual. New York: Springer-Verlag. xiv, 421 p. p.
28. Donders AR, van der Heijden GJ, Stijnen T, Moons KG (2006) Review: a gentle introduction to imputation of missing values. J Clin Epidemiol 59: 1087-1091. (Pubitemid 44374314)
29. Gordon L, Olshen RA (1985) Tree-structured survival analysis. Cancer Treat Rep 69: 1065-1069.
30. Biganzoli E, Boracchi P, Mariani L, Marubini E (1998) Feed forward neural networks for the analysis of censored survival data: a partial logistic regression approach. Stat Med 17: 1169-1186. (Pubitemid 28221032)
31. Harrell FE, Jr., Califf RM, Pryor DB, Lee KL, Rosati RA (1982) Evaluating the yield of medical tests. JAMA 247: 2543-2546. (Pubitemid 12155954)
32. Nash CH, 3rd, Jones SE, Moon TE, Davis SL, Salmon SE (1980) Prediction of outcome in metastatic breast cancer treated with adriamycin combination chemotherapy. Cancer 46: 2380-2388. (Pubitemid 11253695)
33. Hortobagyi GN, Smith TL, Legha SS, Swenerton KD, Gehan EA, et al. (1983) Multivariate analysis of prognostic factors in metastatic breast cancer. J Clin Oncol 1: 776-786. (Pubitemid 14167252)
34. Williams MR, Todd JH, Nicholson RI, Elston CW, Blamey RW, et al. (1986) Survival patterns in hormone treated advanced breast cancer. Br J Surg 73: 752-755. (Pubitemid 16011184)
35. Rabinovich M, Vallejo C, Bianco A, Perez J, Machiavelli M, et al. (1992) Development and validation of prognostic models in metastatic breast cancer: a GOCS study. Oncology 49: 188-195.
36. Yamamoto N, Watanabe T, Katsumata N, Omuro Y, Ando M, et al. (1998) Construction and validation of a practical prognostic index for patients with metastatic breast cancer. J Clin Oncol 16: 2401-2408. (Pubitemid 28309034)
37. Ryberg M, Nielsen D, Osterlind K, Skovsgaard T, Dombernowsky P (2001) Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy. Ann Oncol 12: 81-87. (Pubitemid 32162451)
38. Giordano A, Giuliano M, De Laurentiis M, Eleuteri A, Iorio F, et al. (2011) Artificial neural network analysis of circulating tumor cells in metastatic breast cancer patients. Breast Cancer Res Treat 129: 451-458.
39. Giordano A, Egleston BL, Hajage D, Bland J, Hortobagyi GN, et al. (2013) Establishment and validation of circulating tumor cell-based prognostic nomograms in first-line metastatic breast cancer patients. Clin Cancer Res 19: 1596-1602.
40. Le Scodan R, Massard C, Mouret-Fourme E, Guinebretierre JM, Cohen-Solal C, et al. (2007) Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score. Int J Radiat Oncol Biol Phys 69: 839-845. (Pubitemid 47418410)
41. Nieder C, Marienhagen K, Astner ST, Molls M (2009) Prognostic scores in brain metastases from breast cancer. BMC Cancer 9: 105.
42. Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, et al. (2012) Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases. Int J Radiat Oncol Biol Phys 82: 2111-2117.
43. Ahn HK, Lee S, Park YH, Sohn JH, Jo JC, et al. (2012) Prediction of outcomes for patients with brain parenchymal metastases from breast cancer (BC): a new BC-specific prognostic model and a nomogram. Neuro Oncol 14: 1105-1113.
44. Marko NF, Xu Z, Gao T, Kattan MW, Weil RJ (2012) Predicting survival in women with breast cancer and brain metastasis: a nomogram outperforms current survival prediction models. Cancer 118: 3749-3757.
45. Le Scodan R, Massard C, Jouanneau L, Coussy F, Gutierrez M, et al. (2012) Brain metastases from breast cancer: proposition of new prognostic score including molecular subtypes and treatment. J Neurooncol 106: 169-176.
46. Niwinska A, Murawska M (2012) New breast cancer recursive partitioning analysis prognostic index in patients with newly diagnosed brain metastases. Int J Radiat Oncol Biol Phys 82: 2065-2071.
47. Rades D, Douglas S, Schild SE (2013) A validated survival score for breast cancer patients with metastatic spinal cord compression. Strahlenther Onkol 189: 41-46.
48. Liu MT, Huang WT, Wang AY, Huang CC, Huang CY, et al. (2010) Prediction of outcome of patients with metastatic breast cancer: evaluation with prognostic factors and Nottingham prognostic index. Support Care Cancer 18: 1553-1564.
49. Robertson JF, Dixon AR, Nicholson RI, Ellis IO, Elston CW, et al. (1992) Confirmation of a prognostic index for patients with metastatic breast cancer treated by endocrine therapy. Breast Cancer Res Treat 22: 221-227.
50. Bhoo-Pathy N, Yip CH, Hartman M, Saxena N, Taib NA, et al. (2012) Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients. Eur J Cancer 48: 982-989.
51. Yip CH (2009) Breast cancer in Asia. Methods Mol Biol 471: 51-64.
52. Li CI, Malone KE, Daling JR (2002) Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarkers Prev 11: 601-607. (Pubitemid 34760817)
53. Telli ML, Chang ET, Kurian AW, Keegan TH, McClure LA, et al. (2011) Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry. Breast Cancer Res Treat 127: 471-478.
54. Pal SK, Dehaven M, Nelson RA, Onami S, Hsu J, et al. (2012) Impact of modern chemotherapy on the survival of women presenting with de novo metastatic breast cancer. BMC Cancer 12: 435.
55. Chia SK, Speers CH, D'Yachkova Y, Kang A, Malfair-Taylor S, et al. (2007) The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer. Cancer 110: 973-979. (Pubitemid 47312861)
56. Gradishar WJ (2013) Emerging approaches for treating HER2-positive metastatic breast cancer beyond trastuzumab. Ann Oncol.
57. O'Shaughnessy J (2005) Extending survival with chemotherapy in metastatic breast cancer. Oncologist 10 Suppl 3: 20-29.
58. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, et al. (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351: 781-791. (Pubitemid 39095313)
59. Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, et al. (2005) Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 23: 1420-1430.
60. Balic M, Dandachi N, Hofmann G, Samonigg H, Loibner H, et al. (2005) Comparison of two methods for enumerating circulating tumor cells in carcinoma patients. Cytometry B Clin Cytom 68: 25-30. (Pubitemid 41566360)
61. Muller V, Riethdorf S, Rack B, Janni W, Fasching PA, et al. (2012) Prognostic impact of circulating tumor cells assessed with the CellSearch System and AdnaTest Breast in metastatic breast cancer patients: the DETECT study. Breast Cancer Res 14: R118.